Ocugen Email Format
Biotechnology ResearchPennsylvania, United States51-200 Employees
Ocugen, Inc. is a biotechnology company focused on discovering, developing, and commercializing gene therapies to address major blindness-related diseases. The company operates a modifier gene therapy platform that is gene-agnostic and aims to address unmet medical needs across large patient populations. Ocugen is based in Malvern, Pennsylvania, at 263 Great Valley Parkway, and employs between 51 and 200 people within the biotechnology research industry. The company maintains a website at ocugen.com for information on its activities and programs.